Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: A new license and all we can do is attack each other ,the license program is..

I relabled this post so more might read and discuss.

Emtnester nice post! I am in agreement 100%. Yes, April's no.'s are probably going to be big. But if we have only the licensing to prop up the SP, then we better have some significant names on the list for the next Q or some other significant news that will hold the SP or it will just come back down like it has. I'm in agreement that the only way to break this pattern at this point is to have a reliable revenue stream. I believe that reliable revenue stream could be in the form of ongoing payments Q over Q or year over year by some of these companies that TPL is licensing for large amounts of money. That is, it may be more palitable for some of these companies to spread out the payments rather than have to pay for one lump sum. A payment plan like this may even make it easier to license some of these companies as it would be an easier pill for them to swallow. I believe the share price would respond if PTSC provided some guidance that TPL and PTSC were being flexible in their licensing and allowing more ways to pay other than a one time lump payment plan that we know of at this time.

I'm not great at articulating what I want to say so bare with me.

All the best,

Share
New Message
Please login to post a reply